Senior Vice President, Government Affairs And Policy
CurrentLead government affairs and policy development activities in countries around the world, including the United States. Lead a global team of over 120 people. Advise CEO, Board of Directors and global management team on public policy risks and opportunities, as well as the intersection between public policy, communications and both external and internal drivers of reputation. Oversee FOCUS, a community-based public health program focused on screening, linkage-to-care and best practices partnerships with state and local government entities, health care providers, and other community stakeholders. Chair Gilead Political Action Committee which increased in size by over 140% since 2022. Named a "Top Lobbyist" by The Hill in 2021, 2022, 2023 and 2024. Current Chair of the governing body of the global biopharmaceutical industry trade assocation, IFPMA.